date,title,source
Oct-17-18,"Research Report Identifies Oxford Immunotec Global, Ascena Retail Group, Groupon, Epizyme, Regulus Therapeutics, and B Communications with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Oct-18-18,Regulus Regains Compliance with NASDAQ Listing Requirements,PR Newswire
Oct-22-18,Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018,PR Newswire
Oct-23-18,3 Healthcare Stocks To Watch On Tuesday,ACCESSWIRE
Oct-23-18,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",Benzinga
Oct-25-18,"Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018",PR Newswire
Nov-06-18,Regulus Announces Successful Restructuring of Sanofi Collaboration,PR Newswire
Nov-08-18,"Regulus (RGLS) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,Regulus: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Regulus Reports Third Quarter 2018 Financial Results and Recent Updates,PR Newswire
Nov-19-18,Regulus Presents Preclinical Survival Data Highlighting Potential of Novel Treatment for Glioblastoma Multiforme,PR Newswire
Nov-28-18,"Research Report Identifies Advanced Energy Industries, Altair Engineering, Rambus, Regulus Therapeutics, NN, and Halcon Resources with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Dec-20-18,Need To Know: Regulus Therapeutics Inc. (NASDAQ:RGLS) Insiders Have Been Buying Shares,Simply Wall St.
Jan-04-19,Regulus Announces Preliminary Results of Planned Interim Data Analysis of RGLS4326 in New Mouse Chronic Toxicity Study,PR Newswire
Jan-07-19,Regulus Announces Clinical Candidate Nomination for the Treatment of Glioblastoma Multiforme,PR Newswire
Mar-15-19,Regulus Announces Transition of Research Leadership,PR Newswire
